TCL Archive Conversation With The Cancer Letter: Seffrin To Retire After Restructuring ACS January 24, 2014
TCL Archive Two former Bristol-Myers Squibb executives were indicted as the company agreed to pay $300 million to investors. June 17, 2005
TCL Archive Phase III Data of Antibody-Drug Conjugate Shows PFS Increase in HER2+ Disease June 29, 2012